Asthma Management in Children

Diagnosis and Treatment

The American Academy of Allergy, Asthma, and Immunology recommends that children with a history of atopic dermatitis and wheezing apart from colds be started on daily low-dose inhaled corticosteroids immediately, as they are at high risk for persistent asthma throughout childhood 1
The National Heart, Lung, and Blood Institute guidelines suggest that inhaled corticosteroids are the preferred first-line treatment for mild persistent asthma in children, with budesonide nebulizer solution FDA-approved for children 1-8 years of age and fluticasone DPI approved for children 4 years and older 1
A diagnosis of asthma can be made clinically in young children based on history, symptoms, and therapeutic response, without the need for spirometry or other objective testing 1

The British Thoracic Society recommends providing a written action plan for symptom management and when to seek help, as part of asthma management 2
Regular monitoring of height and weight is recommended to monitor for potential growth effects of corticosteroids, although this fact is not directly cited, it is implied through the importance of monitoring in asthma management, however, reassessing within 4-6 weeks is recommended to evaluate the effectiveness of treatment 1

The American College of Chest Physicians advises against relying on short-acting bronchodilators alone, as they only provide symptom relief and do not modify disease progression or prevent asthma development 1
The European Respiratory Society recommends against delaying treatment waiting for objective testing, as empiric ICS therapy is appropriate in young children with classic presentation and risk factors, while monitoring response 1
The American Thoracic Society suggests that antibiotics have no place in uncomplicated asthma management, and should only be considered after failed therapeutic trial 2

The American Academy of Allergy, Asthma, and Immunology recommends that children under 5 years with recurrent wheezing and a physician diagnosis of atopic dermatitis should be considered for daily long-term control therapy 3, 4
The presence of eczema plus wheezing apart from colds places a child at high risk for persistent asthma throughout childhood 3, 4

Inhaled corticosteroids are the preferred first-line long-term controller medication for initiating therapy in young children with persistent asthma 3, 4, 5
The American Academy of Pediatrics recommends initiating low-dose inhaled corticosteroids, such as fluticasone propionate 100 mcg twice daily or budesonide nebulizer solution, for children with recurrent wheezing 6
A metered-dose inhaler with a valved holding chamber (spacer) and face mask should be used, as children under 4-5 years cannot coordinate standard MDI technique 7, 6
Close monitoring of response to therapy is essential, with reassessment within 4-6 weeks 3, 4, 6

Growth monitoring is essential when using inhaled corticosteroids, as dose-related growth suppression can occur 6
Alternative controller options, such as leukotriene receptor antagonists, may be considered if inhaled medication delivery is suboptimal due to poor technique or adherence 3, 4, 6